MARATTO

article

Predictive Factors of Severe COPD Exacerbation

Abstract

<bold>Introduction:</bold> Severe exacerbations of COPD are critical events that significantly impact patient outcomes. Understanding the predictive factors can aid in early intervention and better management of high-risk patients. <bold>Aim:</bold> identify the predictive factors of severe COPD exacerbation <bold>methods:</bold> This was a prospective study conducted at the pneumology department of Charles Nicolle Hospital, Tunis, from December 2017 to December 2021, including patients with COPD followed for one year. A severe exacerbation was defined as an exacerbation requiring non-invasive ventilation. We performed both univariate and multivariate analyses. <bold>Results:</bold> A total of 121 patients were included. The mean age was 67.17 years. The sex ratio was 7.3. The majority of patients were smokers (93.2%). Chronic respiratory failure (CRF) was noted in 51 patients (42%). During the follow-up, 49 patients (40.5%) had a severe exacerbation. In univariate analysis, patients with severe exacerbations had higher CAT scores for dyspnea (23 vs 19, p=0.01), capnia (46 vs 41, p=0.05), platelet-to-lymphocyte ratio (183 vs 133, p=0.01) and BODE scores (6 vs 4, p=0.01). They also had lower FEV1 (35% vs 46%, p<0.001) and lymphocyte counts (1612 vs 2121, p= 0.004). In multivariate analysis, only FEV1 was independently associated with exacerbation severity (OR = 2.03, 95% CI [1.54, 2.78], p = 0.03). <bold>Conclusions:</bold> FEV1 is an important predictor of severe COPD exacerbations and can help identify patients at higher risk for adverse outcomes

Research topics

  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Respiratory and Cough-Related Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1183/13993003.congress-2025.pa412

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.